Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To examine the association between fetal major heart defects and high nuchal translucency thickness (NT), tricuspid regurgitation and abnormal flow in the ductus venosus in a large population of singleton pregnancies undergoing a routine ultrasound examination at 11‐13 weeks' gestation.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>This was a retrospective study of prospectively collected data from singleton pregnancies attending for a routine ultrasound scan at 11‐13 weeks' gestation which included examination of fetal anatomy, measurement of NT, and assessment of blood flow across the tricuspid valve and in the ductus venosus according to a standardized protocol. The incidence of fetal NT ≥95<sup>th</sup> and NT ≥99<sup>th</sup> percentile, tricuspid regurgitation and reversed a‐wave in the ductus venosus in fetuses with and without major heart defects was determined and the performance of each marker and their combination in the detection of major heart defects was calculated. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The study population of 93,209 pregnancies with no apparent chromosomal abnormality included 211 (0.23%) with major heart defects and 92,998 morphologically normal neonates. In 113 (53.6%) of the major heart defects the diagnosis was made at the 11‐13 weeks scan, in 82 (38.9%) at the 18‐24 weeks scan, in 10 (4.7%) at the third‐trimester scan and in 6 (2.8%) postnatally. At the 11‐13 weeks scan we diagnosed all cases of tricuspid or pulmonary atresia and polyvalvular dysplasia, >90% of cases of hypoplastic left heart syndrome or atrioventricular septal defect, about 60% of complex heart defects and left atrial isomerism (interrupted inferior vena cava with normal intracardiac anatomy), 30‐40% of tetralogy of Fallot and arch abnormalities, 25% of tricuspid valve abnormalities, about 15% of transposition of great arteries, but none of aortic or pulmonary stenosis and common arterial trunk. Fetal NT ≥95<sup>th</sup> percentile, NT ≥99<sup>th</sup> percentile, tricuspid regurgitation, or abnormal ductus venosus flow was observed in 77 (36.5%), 45 (21.3%), 61 (28.9%), and 58 (27.5%) of the fetuses with major heart defects, respectively, and in 5,678 (6.1%), 857 (0.9%), 1,136 (1.2%), and 1,644 (1.8%) of those without heart defects. Any one of NT ≥95<sup>th</sup>, tricuspid regurgitation or abnormal flow in the ductus venosus was found in 117 (55.5%, 95% CI 48.5–62.3%) of the fetuses with heart defects and in 8,166 (8.8%, 95% CI 8.6‐9.0%) of those without heart defects. Any one of NT ≥99<sup>th</sup> percentile and the other two markers was found in 99 of the fetuses with heart defects (46.9%, 95% CI 40.0‐53.9%) and in 3,517 of those without heart defects (3.8%, 95% CI 3.7‐3.9%). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>At 11‐13 weeks' gestation measurement of fetal NT and assessment of flow across the tricuspid valve and in the ductus venosus can lead to the early diagnosis of major heart defects.</p><p>This article is protected by copyright. All rights reserved.</p></section>

EP18.28: Association of chromosomal abnormalities and cardiac defects with increased nuchal translucency and/or ductus venosus PI>1.3 in South Indian population

EP18.20: Association of chromosomal abnormalities and cardiac defects with increased nuchal translucency and/or tricuspid regurgitation in South Indian population

EP18.31: Impact of increased nuchal translucency values on pregnancy outcomes

EP18.32: Increased nuchal translucency and cystic hygroma: pregnancy outcomes

EP09.59: Fetal aberrant right subclavian artery: insights into association with additional soft markers, structural and chromosomal anomalies

Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35

EP18.13: Can combining second trimester quadruple test with mid‐trimester anomaly scan for soft markers and defects improve detection of chromosomal anomalies?

A Chinese multicenter retrospective study of isolated increased nuchal translucency associated chromosome anomaly and prenatal diagnostic suggestions

EP05.36: Association of prenatal conatal cysts with structural and genetic anomalies

EP18.46: Kabuki‐Syndrome in a fetus with thickened nuchal translucency and congenital corrected transposition of the great arteries

EP18.10: Isolated unossified nasal bone in the first trimester: does it really improve Trisomy 21 detection? Experiences from Southern India

Measurement of Nuchal Translucency Thickness for Detection of Chromosomal Abnormalities using First Trimester Ultrasound Fetal Images

Fetal Heart Rate Patterns and Umbilical Artery Flow Velocity Waveforms in Pregnancies with Trisomy 21

Abstract 16738: Association Between First and Second Trimester Maternal Screening Biochemistry, Ultrasound, and Fetal Brain Growth in Presence of Fetal or Maternal Congenital Heart Disease

Congenital Heart Diseases: Risk Factors and Ultrasound Diagnostic Potential at the First Screening

Diagnosis of major heart defects by routine first‐trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus

The relationship between increment of nuchalsknfold thickness and chromosomally abnormal fetuses

EP06.66: Microtia and anotia have strong association with congenital heart diseases and IUGR

Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study

Recurrent Increased Nuchal Translucency Led to the Identification of Novel NUP107 Variants

Genetic correlation between fetal nuchal translucency thickening and cystic hygroma and exploration of pregnancy outcome